These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Cardiovascular biomarkers in the ICU. Noveanu M; Mebazaa A; Mueller C Curr Opin Crit Care; 2009 Oct; 15(5):377-83. PubMed ID: 19606027 [TBL] [Abstract][Full Text] [Related]
25. The prognostic use of right heart catheterization data in patients with advanced heart failure: how relevant are invasive procedures in the risk stratification of advanced heart failure in the era of neurohormones? Gardner RS; Henderson G; McDonagh TA J Heart Lung Transplant; 2005 Mar; 24(3):303-9. PubMed ID: 15737757 [TBL] [Abstract][Full Text] [Related]
26. Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. Kociol RD; Pang PS; Gheorghiade M; Fonarow GC; O'Connor CM; Felker GM J Am Coll Cardiol; 2010 Sep; 56(14):1071-8. PubMed ID: 20863950 [TBL] [Abstract][Full Text] [Related]
27. Biochemical markers in heart failure. Sato Y; Fujiwara H; Takatsu Y J Cardiol; 2012 Jan; 59(1):1-7. PubMed ID: 22138007 [TBL] [Abstract][Full Text] [Related]
28. BNP in the diagnosis and risk stratification of heart failure. Moe GW Heart Fail Monit; 2005; 4(4):116-22. PubMed ID: 16234898 [TBL] [Abstract][Full Text] [Related]
29. Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial. Anand IS; Kempf T; Rector TS; Tapken H; Allhoff T; Jantzen F; Kuskowski M; Cohn JN; Drexler H; Wollert KC Circulation; 2010 Oct; 122(14):1387-95. PubMed ID: 20855664 [TBL] [Abstract][Full Text] [Related]
30. Natriuretic peptides in the diagnosis and management of acute heart failure. Mohammed AA; Januzzi JL Heart Fail Clin; 2009 Oct; 5(4):489-500. PubMed ID: 19631174 [TBL] [Abstract][Full Text] [Related]
31. Emerging cardiac markers in coronary disease: role of brain natriuretic peptide and other biomarkers. Palazzuoli A; Iovine F; Gallotta M; Nuti R Minerva Cardioangiol; 2007 Aug; 55(4):491-6. PubMed ID: 17653025 [TBL] [Abstract][Full Text] [Related]
32. Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. Maisel A; Mueller C; Nowak RM; Peacock WF; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand I; Ng LL; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Hartmann O; Morgenthaler NG; Anker SD J Am Coll Cardiol; 2011 Aug; 58(10):1057-67. PubMed ID: 21867843 [TBL] [Abstract][Full Text] [Related]
33. Biomarkers of myocyte injury in heart failure. Latini R; Masson S Heart Fail Clin; 2009 Oct; 5(4):529-36. PubMed ID: 19631177 [TBL] [Abstract][Full Text] [Related]
34. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. Maisel A; Mueller C; Nowak R; Peacock WF; Landsberg JW; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand I; Ng L; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Terracciano G; Kremastinos D; Hartmann O; von Haehling S; Bergmann A; Morgenthaler NG; Anker SD J Am Coll Cardiol; 2010 May; 55(19):2062-76. PubMed ID: 20447528 [TBL] [Abstract][Full Text] [Related]